Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Wolber

Showing results (141-150 of 213) with videos related to

Pageof 22
Sort By:
Frontiers in Microbiology|May 30, 2023
Crystal structures of glycoprotein D of equine alphaherpesviruses reveal potential binding sites to the entry receptor MHC-IViviane Kremling, Bernhard Loll, Szymon Pach, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2011
Pharmacophore-based discovery of a novel cytosolic phospholipase A(2)α inhibitorStefan M Noha, Bianca Jazzar, Susanne Kuehnl, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2018
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complicationsRosanna Maccari, Antonella Del Corso, Paolo Paoli, et al.
Bioimpacts : BI|March 31, 2025
Anti-Alzheimer effects of the newly synthesized cationic compounds as multi-target dual hAChE/hBuChE inhibitor: An <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> approachHosna Karami, Somaieh Soltani, Gerhard Wolber, et al.
Journal of Medicinal Chemistry|July 23, 2014
Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivityJens Schmitz, Dorina van der Mey, Marcel Bermudez, et al.
Chemmedchem|April 17, 2015
Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivoStefanie Grosskopf, Chris Eckert, Christoph Arkona, et al.
Journal of Medicinal Chemistry|December 18, 2009
Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadaiUlrike Grienke, Michaela Schmidtke, Johannes Kirchmair, et al.
European Journal of Medicinal Chemistry|November 16, 2016
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agentsRosaria Ottanà, Paolo Paoli, Alexandra Naß, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 13, 2019
Fine-mapping of the substrate specificity of human steroid 21-hydroxylase (CYP21A2)Anna Stoll, Steffen Loke, Jan Felix Joseph, et al.
European Journal of Medicinal Chemistry|September 1, 2023
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinaseFederico Ricci, Kristina Schira, Lyna Khettabi, et al.
Pageof 22

Showing results (141-150 of 213) with videos related to

Sort By:
Pageof 22
Frontiers in Microbiology|May 30, 2023
Crystal structures of glycoprotein D of equine alphaherpesviruses reveal potential binding sites to the entry receptor MHC-IViviane Kremling, Bernhard Loll, Szymon Pach, et al.
Bioorganic & Medicinal Chemistry Letters|December 24, 2011
Pharmacophore-based discovery of a novel cytosolic phospholipase A(2)α inhibitorStefan M Noha, Bianca Jazzar, Susanne Kuehnl, et al.
Bioorganic & Medicinal Chemistry Letters|October 22, 2018
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complicationsRosanna Maccari, Antonella Del Corso, Paolo Paoli, et al.
Bioimpacts : BI|March 31, 2025
Anti-Alzheimer effects of the newly synthesized cationic compounds as multi-target dual hAChE/hBuChE inhibitor: An <i>in silico</i>, <i>in vitro</i>, and <i>in vivo</i> approachHosna Karami, Somaieh Soltani, Gerhard Wolber, et al.
Journal of Medicinal Chemistry|July 23, 2014
Dualsteric muscarinic antagonists--orthosteric binding pose controls allosteric subtype selectivityJens Schmitz, Dorina van der Mey, Marcel Bermudez, et al.
Chemmedchem|April 17, 2015
Selective inhibitors of the protein tyrosine phosphatase SHP2 block cellular motility and growth of cancer cells in vitro and in vivoStefanie Grosskopf, Chris Eckert, Christoph Arkona, et al.
Journal of Medicinal Chemistry|December 18, 2009
Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadaiUlrike Grienke, Michaela Schmidtke, Johannes Kirchmair, et al.
European Journal of Medicinal Chemistry|November 16, 2016
Discovery of 4-[(5-arylidene-4-oxothiazolidin-3-yl)methyl]benzoic acid derivatives active as novel potent allosteric inhibitors of protein tyrosine phosphatase 1B: In silico studies and in vitro evaluation as insulinomimetic and anti-inflammatory agentsRosaria Ottanà, Paolo Paoli, Alexandra Naß, et al.
The Journal of Steroid Biochemistry and Molecular Biology|August 13, 2019
Fine-mapping of the substrate specificity of human steroid 21-hydroxylase (CYP21A2)Anna Stoll, Steffen Loke, Jan Felix Joseph, et al.
European Journal of Medicinal Chemistry|September 1, 2023
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinaseFederico Ricci, Kristina Schira, Lyna Khettabi, et al.
Pageof 22